These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34950840)

  • 1. Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma.
    Iuchi H; Ohori J; Matsuzaki H; Kiyama S; Yamashita M
    OTO Open; 2021; 5(4):2473974X211067423. PubMed ID: 34950840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of Inflammation-Based Prognostic Scores on Survival in Patients With Hypopharyngeal Squamous Cell Carcinoma.
    Iuchi H; Kyutoku T; Ito K; Matsumoto H; Ohori J; Yamashita M
    OTO Open; 2020; 4(4):2473974X20978137. PubMed ID: 33447693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study.
    Tsai YT; Fang KH; Hsu CM; Lai CH; Chang SW; Huang EI; Tsai MS; Chang GH; Luan CW
    Front Oncol; 2022; 12():825967. PubMed ID: 35242712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer.
    Hanai N; Sawabe M; Kimura T; Suzuki H; Ozawa T; Hirakawa H; Fukuda Y; Hasegawa Y
    Oncotarget; 2018 Dec; 9(97):37008-37016. PubMed ID: 30651931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
    Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
    Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of the high-sensitivity modified glasgow prognostic score on patients undergoing radical surgery for hepatocellular carcinoma : Authorship.
    Luo B; Zhang Y; Zhu X; Ji T; Wu K; Sun D; Lu Y; Shi L
    Langenbecks Arch Surg; 2024 Jul; 409(1):223. PubMed ID: 39023651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of systemic inflammation and nutrition-based prognostic indices in oropharyngeal carcinoma.
    Oka T; Sato F; Ono T; Kawaguchi T; Murotani K; Sueyoshi S; Kuroiwa T; Kurita T; Fukahori M; Mitsuhashi T; Sato K; Chitose SI; Umeno H
    Laryngoscope Investig Otolaryngol; 2023 Jun; 8(3):675-685. PubMed ID: 37342125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
    Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
    Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
    Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation.
    Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K
    World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy.
    Chen P; Fang M; Wan Q; Zhang X; Song T; Wu S
    Oncotarget; 2017 Nov; 8(59):99861-99870. PubMed ID: 29245945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis.
    Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the High-Sensitivity Modified Glasgow Prognostic Scores for Oropharyngeal Carcinoma.
    Iuchi H; Ohori J; Ando Y; Tokushige T; Haraguchi M; Yamashita M
    OTO Open; 2021; 5(3):2473974X211042302. PubMed ID: 34568723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
    Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
    Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel.
    Ando K; Sakamoto S; Saito S; Maimaiti M; Imamura Y; Sazuka T; Sato N; Komiya A; Anzai N; Ichikawa T
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33673284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of handgrip strength and high-sensitivity modified Glasgow prognostic score predicts survival outcomes in patients with colon cancer.
    Shi Y; Sun Y; Shen X; Yang Z; Xu B; Bao C
    Front Nutr; 2024; 11():1421560. PubMed ID: 39010859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the treatment outcome of nivolumab in recurrent or metastatic head and neck squamous cell carcinoma: prognostic value of combined performance status and modified Glasgow prognostic score.
    Ueki Y; Takahashi T; Ota H; Shodo R; Yamazaki K; Horii A
    Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2341-2347. PubMed ID: 32239313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score-matched analysis.
    Cui C; Wu X; Deng L; Wang W; Cui W; Wang Y
    Thorac Cancer; 2022 Jul; 13(14):2041-2049. PubMed ID: 35624549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.